NCT02047409
Unknown
Not Applicable
Prognostic Value of Oscillatory Pattern of Sympathetic Nerve Activity Muscle in Patients With Heart Failure
ConditionsHeart Failure
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- University of Sao Paulo General Hospital
- Enrollment
- 160
- Locations
- 1
- Primary Endpoint
- Peripheral autonomic control
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to determine whether oscillatory pattern of sympathetic nerve activity muscle is an efficient index for the prognosis of patients with heart failure.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with systolic heart failure and New York Heart Association (NYHA)
- •Ischemic, hypertensive, or idiopathic etiology
- •Left ventricular ejection fraction less than 40%
Exclusion Criteria
- •Neuromuscular, Orthopedic, Neurologic and Pulmonary Diseases
- •Renal failure
- •Diabetes mellitus type II
Outcomes
Primary Outcomes
Peripheral autonomic control
Time Frame: 12 months
Evaluate if the reduction in the oscillatory pattern of muscle sympathetic nerve activity is associated with morbidity and mortality in patients with heart failure in a clinical follow-up 12 months
Secondary Outcomes
- Blood inflammatory markers(12 months)
- Functional Capacity(12 months)
- Arterial baroreflex control(12 months)
- Cardiac and peripheral autonomic control(12 months)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Cardiac sympathetic nervous system function and activity as a predictor for appropriate implantable cardioverter defibrillator (ICD) therapy in patients with chronic heart failure.chronic heart failure, sympathetic cardiac activity, 123I-MIBGNL-OMON21166Academic Medical Center, University of Amsterdam, the Netherlands300
Completed
Not Applicable
Sympathetic Nerve Activity and an Implantable Cardioverter Defibrillator in Heart Failure PatientsHeart FailureDeath, Sudden, CardiacNCT00439790University Hospital, Toulouse109
Completed
Phase 4
Prognostic Value of Cardiac Sympathetic Nerve Activity Evaluated by 123I-Metaiodobenzylguanidine Imaging in Patients with ST-Segment Elevation Myocardial InfarctioST-segment elevation myocardial infarctionJPRN-UMIN000001380Kitakanto Cardiovascular Hospital200
Withdrawn
Not Applicable
Sympathetic Innervation of the Heart and Cardiac Resynchronization Therapy(CRT)Sympathetic InnervationChronic Heart FailureNCT00567645University Medical Center Groningen
Withdrawn
Phase 4
Sympathetic Nerve Activity in Renal FailureChronic Kidney DiseaseHypertensionNCT00892892University of Erlangen-Nürnberg Medical School